Takeda is set to gulp up Shire whether disgruntled investors like the deal or not, but its new FDA OK may make it easier to swallow.

The FDA’s Center for Veterinary Medicine has reached an agreement for Pfizer to divert part of a new source of injected pain drugs to veterinarians.

Trial lawyer "bad drug" TV ads need better regulation, a new coalition of national patient and physician advocacy groups says.

Boehringer has teamed up for a second year with the Bonnie J. Addario Lung Cancer Foundation to bring holiday cheer directly to lung cancer patients.

Investors sent J&J's shares down Friday after Reuters reported on court documents detailing the company's internal debates over asbestos in talc.

Teva has already decided to move its U.S. headquarters, and now it’s planning to move its worldwide headquarters, too.

Generic drug makers scored a win at the FDA as the agency changed its mind on giving them responsibility to update their labels.

Merck, one of the few Big Pharmas forging ahead in animal health, will plunk down €2.1 billion to move into digital tracking for livestock and pets.

India scrutinizes whistleblower case against Sun; FDA slaps warning letter on valsartan API maker; Eisai and UCL push anti-tau drug into the clinic.

AstraZeneca felt the blow last month when key trial Mystic failed. But now that the dust has settled, it's looking for bright spots in the miss.